• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The SPIRIT Checklist-lessons from the experience of SPIRIT protocol editors.《SPIRIT 清单——来自 SPIRIT 方案编辑经验的教训》
Trials. 2022 Apr 27;23(1):359. doi: 10.1186/s13063-022-06316-7.
2
Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study.自《标准协议条目:干预试验建议》(SPIRIT)声明发布以来,已发表的随机对照试验方案的报告质量是否有所提高?一项方法学研究。
BMJ Open. 2020 Aug 26;10(8):e038283. doi: 10.1136/bmjopen-2020-038283.
3
Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects.重复横断面研究评估试验方案报告质量的原理与设计:遵循《渥太华小组声明》建议(ASPIRE)研究及相关项目
Trials. 2020 Oct 28;21(1):896. doi: 10.1186/s13063-020-04808-y.
4
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension.涉及人工智能干预的临床试验方案指南:SPIRIT-AI 扩展。
BMJ. 2020 Sep 9;370:m3210. doi: 10.1136/bmj.m3210.
5
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.涉及人工智能干预的临床试验方案指南:SPIRIT-AI 扩展。
Lancet Digit Health. 2020 Oct;2(10):e549-e560. doi: 10.1016/S2589-7500(20)30219-3. Epub 2020 Sep 9.
6
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.涉及人工智能干预的临床试验方案指南:SPIRIT-AI 扩展。
Nat Med. 2020 Sep;26(9):1351-1363. doi: 10.1038/s41591-020-1037-7. Epub 2020 Sep 9.
7
[Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extensionDiretrizes para protocolos de ensaios clínicos com intervenções que utilizam inteligência artificial: a extensão SPIRIT-AI].[人工智能干预临床试验方案指南:SPIRIT-AI扩展版 人工智能干预临床试验方案指南:SPIRIT-AI扩展版]
Rev Panam Salud Publica. 2023 Feb 1;48:e12. doi: 10.26633/RPSP.2024.12. eCollection 2024.
8
[Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extensionDiretrizes para protocolos de ensaios clínicos com intervenções que utilizam inteligência artificial: a extensão SPIRIT-AI].[人工智能干预临床试验方案指南:SPIRIT-AI扩展版 关于使用人工智能的干预措施的临床试验方案指南:SPIRIT-AI扩展版]
Rev Panam Salud Publica. 2023 Dec 8;47:e149. doi: 10.26633/RPSP.2023.149. eCollection 2023.
9
SPIRIT 2013 statement: defining standard protocol items for clinical trials.SPIRIT 2013 声明:定义临床试验的标准议定书项目。
Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.
10
SPIRIT 2013 Statement: defining standard protocol items for clinical trials.《SPIRIT 2013声明:临床试验标准方案项目的定义》
Rev Panam Salud Publica. 2015 Dec;38(6):506-14.

引用本文的文献

1
Pericardiectomy with routine cardiopulmonary bypass: a multicenter, randomized controlled trial.常规体外循环下心包切除术:一项多中心随机对照试验
Trials. 2025 Apr 23;26(1):138. doi: 10.1186/s13063-025-08843-5.
2
Dermatitis during adjuvant irradiation for breast cancer (DAI-BREAC): a randomized controlled trial investigating whether grade ≥2 dermatitis during radiotherapy for breast cancer can be reduced by a mobile application that reminds patients to perform skin care.乳腺癌辅助放疗期间的皮炎(DAI-BREAC):一项随机对照试验,旨在研究一款提醒患者进行皮肤护理的移动应用程序是否能减少乳腺癌放疗期间≥2级皮炎的发生。
Trials. 2025 Mar 20;26(1):99. doi: 10.1186/s13063-025-08800-2.
3
Empowerment and mobile technology in the detection and treatment of main cardiovascular risk factors of patients with ischemic stroke or transient ischemic attack: a protocol for a multicenter randomized controlled trial (CARDIOSTROKE).缺血性中风或短暂性脑缺血发作患者主要心血管危险因素检测与治疗中的赋权与移动技术:一项多中心随机对照试验(CARDIOSTROKE)方案
Trials. 2025 Mar 14;26(1):89. doi: 10.1186/s13063-025-08778-x.
4
Reporting Quality of Endoscopic Colorectal Cancer Screening Randomized Controlled Trials: Adherence to Recommendations and Interventions.内镜下结直肠癌筛查随机对照试验的报告质量:对建议和干预措施的遵循情况
Gastro Hep Adv. 2024 Jun 21;3(7):1012-1019. doi: 10.1016/j.gastha.2024.06.003. eCollection 2024.
5
General skin and nasal decolonization with octenisan® set before and after elective orthopedic surgery in selected patients at elevated risk for revision surgery and surgical site infections-a single-center, unblinded, superiority, randomized controlled trial (BALGDEC trial).在选择的高风险翻修手术和手术部位感染的患者中,在择期矫形外科手术前后使用奥替尼定®进行常规皮肤和鼻腔去定植-一项单中心、非盲、优效性、随机对照试验(BALGDEC 试验)。
Trials. 2024 Jul 8;25(1):461. doi: 10.1186/s13063-024-08173-y.
6
Enhancing reporting through structure: a before and after study on the effectiveness of SPIRIT-based templates to improve the completeness of reporting of randomized controlled trial protocols.通过结构化提高报告质量:一项关于基于SPIRIT模板提高随机对照试验方案报告完整性有效性的前后对照研究。
Res Integr Peer Rev. 2024 May 31;9(1):6. doi: 10.1186/s41073-024-00147-7.
7
Broad-spectrum antibiotic prophylaxis in tumor and infected orthopedic surgery-the prospective-randomized, microbiologist-blinded, stratified, superiority trials: BAPTIST Trials.广谱抗生素预防肿瘤和感染性骨科手术-前瞻性随机、微生物学家盲法、分层、优效性试验:BAPTIST 试验。
Trials. 2024 Jan 19;25(1):69. doi: 10.1186/s13063-023-07605-5.
8
Raising awareness of sex and gender bias in artificial intelligence and health.提高对人工智能与健康领域中性别偏见的认识。
Front Glob Womens Health. 2023 Sep 6;4:970312. doi: 10.3389/fgwh.2023.970312. eCollection 2023.
9
The effect of perioperative of dexamethasone on postoperative complications after pancreaticoduodenectomy (PANDEX): a study protocol for a pragmatic multicenter randomized controlled trial.地塞米松在胰十二指肠切除术后(PANDEX)对术后并发症的影响:一项实用多中心随机对照试验的研究方案。
Trials. 2023 Sep 2;24(1):569. doi: 10.1186/s13063-023-07571-y.
10
Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial.利伐沙班在伴有高敏 C 反应蛋白升高的腹主动脉瘤患者中的应用(BANBOO):一项随机、对照试验的研究方案。
Trials. 2023 Jun 19;24(1):419. doi: 10.1186/s13063-023-07461-3.

本文引用的文献

1
A study protocol for the development of a SPIRIT extension for trials conducted using cohorts and routinely collected data (SPIRIT-ROUTINE).一项关于开发用于使用队列和常规收集数据进行试验的SPIRIT扩展版(SPIRIT-ROUTINE)的研究方案。
HRB Open Res. 2021 Jul 29;4:82. doi: 10.12688/hrbopenres.13314.1. eCollection 2021.
2
Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension.临床试验方案中细胞和分子病理学内容的指南:SPIRIT-Path 扩展。
Lancet Oncol. 2021 Oct;22(10):e435-e445. doi: 10.1016/S1470-2045(21)00344-2.
3
SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.SPIRIT-PRO 扩展说明和阐述:临床试验方案中纳入患者报告结局的指南。
BMJ Open. 2021 Jun 30;11(6):e045105. doi: 10.1136/bmjopen-2020-045105.
4
Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects.重复横断面研究评估试验方案报告质量的原理与设计:遵循《渥太华小组声明》建议(ASPIRE)研究及相关项目
Trials. 2020 Oct 28;21(1):896. doi: 10.1186/s13063-020-04808-y.
5
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.涉及人工智能干预的临床试验方案指南:SPIRIT-AI 扩展。
Nat Med. 2020 Sep;26(9):1351-1363. doi: 10.1038/s41591-020-1037-7. Epub 2020 Sep 9.
6
Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study.自《标准协议条目:干预试验建议》(SPIRIT)声明发布以来,已发表的随机对照试验方案的报告质量是否有所提高?一项方法学研究。
BMJ Open. 2020 Aug 26;10(8):e038283. doi: 10.1136/bmjopen-2020-038283.
7
Methodological aspects of superiority, equivalence, and non-inferiority trials.优势、等效和非劣效试验的方法学方面。
Intern Emerg Med. 2020 Sep;15(6):1085-1091. doi: 10.1007/s11739-020-02450-9. Epub 2020 Jul 23.
8
Effect of an editorial intervention to improve the completeness of reporting of randomised trials: a randomised controlled trial.提高随机试验报告完整性的编辑干预效果:一项随机对照试验。
BMJ Open. 2020 May 18;10(5):e036799. doi: 10.1136/bmjopen-2020-036799.
9
SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist.针对单病例试验的SPIRIT扩展与细化:2019年SPENT清单
BMJ. 2020 Feb 27;368:m122. doi: 10.1136/bmj.m122.
10
Protocols-more structure, less 'Wuthering Heights'.方案——更具条理性,少些《呼啸山庄》式的随意。
Trials. 2019 Nov 28;20(1):649. doi: 10.1186/s13063-019-3865-7.

《SPIRIT 清单——来自 SPIRIT 方案编辑经验的教训》

The SPIRIT Checklist-lessons from the experience of SPIRIT protocol editors.

作者信息

Qureshi Riaz, Gough Alexander, Loudon Kirsty

机构信息

Department of Ophthalmology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA.

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

出版信息

Trials. 2022 Apr 27;23(1):359. doi: 10.1186/s13063-022-06316-7.

DOI:10.1186/s13063-022-06316-7
PMID:35477436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9044711/
Abstract

Crystal clear RCT protocols are of paramount importance. The reader needs to easily understand the trial methodology and know what is pre-planned. They need to know there are procedures in place if there are, for instance, protocol breaches and protocol amendments are required, there is loss to follow-up and missing data, and how solicited and spontaneous reported adverse events are dealt with. This plan is important for the trial and for the results that will be published when the data is analysed. After all, individuals have consented to participate in these trials, and their time and their well-being matter. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) provides guidance to structure RCT protocols and ensures all essential information is included. But sadly, not all trialists follow the guidance, and sometimes, the information is misunderstood. Using experience peer-reviewing for Trials over the last 2 years, we have prepared information to assist authors, peer reviewers, editors, and other current and future SPIRIT protocol editors to use the SPIRIT guidance and understand its importance.

摘要

清晰明确的随机对照试验方案至关重要。读者需要轻松理解试验方法,并知晓预先规划的内容。他们需要知道,如果出现例如违反方案、需要修正方案、失访和数据缺失等情况,以及如何处理主动报告和自发报告的不良事件,都有相应的程序。该方案对于试验以及分析数据时即将发表的结果都很重要。毕竟,个体已同意参与这些试验,他们的时间和健康至关重要。《标准方案项目:干预性试验建议》(SPIRIT)为构建随机对照试验方案提供指导,并确保纳入所有必要信息。但遗憾的是,并非所有试验者都遵循该指导,有时信息也会被误解。基于过去两年对试验进行同行评审的经验,我们编写了相关资料,以帮助作者、同行评审人员、编辑以及其他当前和未来的SPIRIT方案编辑人员使用SPIRIT指导并理解其重要性。